scholarly journals Assisted Reproductive Technology and the Reproductive Behavior of Urban Youth (Experience of a Pilot Study)

REGIONOLOGY ◽  
2019 ◽  
Vol 27 (1) ◽  
pp. 138-155
Author(s):  
Tatiana M. Dadaeva ◽  
Victoria V. Baranova

Introduction. The use of assisted reproductive technology in a situation of a demographic crisis can contribute to an increase in the birth rate among childless parents. The paper is of relevance as there is a need for a sociological analysis of the youth’s attitudes towards the use of assisted reproductive technology. The purpose of the article is to reveal significant factors affecting the youth’s attitudes towards assisted reproductive technology and its application, based on the results of a case study conducted among young people residing in the city of Saransk. Materials and Methods. The study used the methods of analysis, comparison and correlation. The data of a pilot survey conducted among young people residing in the city of Saransk and statistics were used as the empirical base of the study. The data were collected on the basis of the methodology developed by the authors according to quota sampling (by sex, age and place of residence). Results. The study has revealed the correlation between the respondents’ awareness of assisted reproductive technology and their level of education, age and marital status. It has been established that those respondents who took advantage of assisted reproductive technology, more often used such methods as in vitro fertilization, intracytoplasmic sperm injection and surrogacy. The authors have formulated proposals on the need for the state to increase funding for the assisted reproductive technology programs, when it concerns reproductive health, to allocate quotas, ensuring the availability of the technology for the enforcement of the reproductive rights in society, as well as to inform the public about new types of assisted reproductive technology. Discussion and Conclusion. The results of the study can be used by the authorities, staff of reproductive health centers and in vitro fertilization clinics to develop and plan assisted reproductive technology programs, for conducting monitoring studies on the use of assisted reproductive technology. Prospects for the study are associated with conducting further in-depth qualitative research on parents using assisted reproductive technology.

Author(s):  
Marie Boltz ◽  
Holly Rau ◽  
Paula Williams ◽  
Holly Rau ◽  
Paula Williams ◽  
...  

2016 ◽  
Vol 105 (4) ◽  
pp. 927-931.e3 ◽  
Author(s):  
David Kulak ◽  
Sangita K. Jindal ◽  
Cheongeun Oh ◽  
Sara S. Morelli ◽  
Scott Kratka ◽  
...  

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. 38-44
Author(s):  
Anna G. Burduli ◽  
Natalia A. Kitsilovskaya ◽  
Yuliya V. Sukhova ◽  
Irina A. Vedikhina ◽  
Tatiana Yu. Ivanets ◽  
...  

Aim. To assess the possibility of using androstenedione levels in blood serum and follicular fluid to predict ovarian response in assisted reproductive technology programs and to conduct a comparative analysis of the results obtained by 2 methods chemiluminescent immunoassay (CLIA) and high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Materials and methods. A prospective study included 55 couples who received in vitro fertilization/intracytoplasmic sperm injection and embryo transfer program therapy. The patients were divided into 3 groups depending on the ovarian response to stimulation: 1st (13 oocytes, n=4), 2nd (49 oocytes, n=27), 3rd (over 10 oocytes, n=24). Androstenedione levels were measured in blood serum obtained on the day of transvaginal ovarian puncture and in follicular fluid samples with CLIA and HPLC-MS/ MS methods at the laboratories of Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology. Results. On the day of transvaginal ovarian puncture, the serum androstenedione levels, which were measured by HPLC-MS/MS, were increasing with an increase of the number of oocytes obtained. The CLIA method revealed a difference in the androstenedione levels between the groups with the number of oocytes obtained of less than 3 and more than 10. Moreover, the androstenedione levels measured by CLIA were significantly different between the patient groups (p0.05). Comparison of serum androstenedione levels measured by CLIA and HPLC-MS/MS, showed high correlations between the values [=0.73 (p0.001)], which makes it possible to use both methods equally, given the existing equipment of the clinical base. Conclusion. Prediction of ovarian response to stimulation is an important step in assisted reproductive technology programs. Measuring androstenedione concentration in blood serum on the day of transvaginal ovarian puncture with highly specific methods (CLIA and HPLC-MS/MS) can be used to predict the degree of ovarian response along with the traditional assessment of the ovarian reserve based on determining anti-Mullerian hormone levels in the early follicular phase of the menstrual cycle.


2018 ◽  
Author(s):  
Jessica R Zolton ◽  
Rhea Chattopadhyay ◽  
Alan H. DeCherney

Assisted reproductive technology (ART) encompasses all procedures that manipulate the oocytes, sperm, and embryos outside of the body. Decades of research have allowed the field to emerge as a reliable and safe treatment for infertile men and women. Indications for in vitro fertilization (IVF) include tubal factor infertility, anovulation, male factor infertility, and decreased ovarian reserve. Treatment is not limited to the infertile population, as IVF with preimplantation genetic diagnosis also offers patients an opportunity to prevent transmission of a genetic condition for which they have been found to carry. The field of ART continues to rapidly evolve, as more knowledge is gained from studies reporting on ovarian stimulation protocols, reproductive techniques such as intracytoplasmic sperm injection, and blastocyst transfer. Techniques are aimed to improve live birth rates while ensuring the optimal health of children conceived using IVF. This review contains 8 figures, 5 tables and 63 references Key Words: assisted reproductive technology, blastocyst, decreased ovarian reserve, embryo transfer, gonadotropin-releasing hormone agonist, gonadotropin-releasing hormone antagonist, intracytoplasmic sperm injection, luteal phase support, ovarian hyperstimulation syndrome, vitrification


Sign in / Sign up

Export Citation Format

Share Document